Jacksonville, FL, Sept. 20, 2022 (GLOBE NEWSWIRE) — Blockchain Moon Acquisition Corp. (“BMAC”) (Nasdaq: BMAQ) announces that on September 14, 2022, John P. Hopkins and Carl J. Johnson were appointed to the Board as new independent directors.
“We are pleased to have two extremely experienced directors added to the Board as independent directors. Their backgrounds as CEOs, officers and advisors will greatly benefit the shareholders of Blockchain Moon Acquisition Corp.,” commented Enzo Villani, Chairman and Chief Executive Officer of BMAC.
Mr. Hopkins has 40 years of experience in accounting, finance and operations, business restructuring, acquisitions and divestitures, debt restructuring and information technology. Most recently, Mr. Hopkins served as President and CEO of Professional Security Broadband Inc., a privately held provider of integrated security, managed services and business intelligence systems to Fortune 500 companies. As President and CEO, he was responsible for organic revenue growth from $18 million in 2012 to $75 million in 2021 and drove the creation of PSB Exero, an industry-disrupting private cloud-based business intelligence tool that provides a NIST system level. documentation and cyber defense for security. Mr. Hopkins began his career at Big 4 public accounting firm PricewaterhouseCoopers, where he rose to the level of Audit Manager. Mr. Hopkins was subsequently employed in the roles of Senior Manager at ARCO Chemical Company, Vice President Finance at Cambrex Corporation, Chief Financial Officer for Measurement Specialties, Inc., and Chief Financial Officer at Henry Brothers Electronics (NASDAQ: HBE). Mr. Hopkins also has extensive experience in creating scalable enterprise automation platforms, as well as in leading business and accounting process rework and turnarounds. Along with his leadership career, Mr. Hopkins served on the Board of Professional Security Broadband Inc. from 2011 to 2021 and on the Felician University School of Business Advisory Board from 2019 to 2021. He is also a member of the American Institute of Certified Public Accountants. In addition, Mr. Hopkins currently teaches at New York University Leonard N. School of Business, Seton Hall University Stillman School of Business, Seton Hall University School of Law, and formerly at Felician University School of Business. Mr. Hopkins holds an MBA from Villanova University and a bachelor’s degree in accounting from West Chester University.
Mr. Johnson has over 40 years of marketing and sales experience in consumer healthcare. In 2019, Mr. Johnson founded Four Peaks Insight, LLC, a business development and executive coaching firm. He is also currently a member of ExecHQ, a consulting firm. Previously, Mr. Johnson served as President and Chief Executive Officer and as a member of the Board of Directors of Entia Biosciences, Inc., a clinical-stage biotechnology company engaged in the development of pharmaceutical-grade organic compounds, from August 2015 to November 2017. Mr. Johnson served as President and CEO and as a member of the Board of Directors of Matrixx Initiatives, Inc., a marketer of over-the-counter (“OTC”) health products, from July 2001 to October 2008, and again as a member of the Board of Directors of Matrixx Initiatives from February 2011 to February 2014. From 1993 to 2001, Mr. Johnson was Vice President of Commercial Development at Perrigo Company, a leading manufacturer of pharmaceutical and nutritional OTC products for the store brand market. Prior to that, Mr. Johnson held a number of senior marketing and sales positions at Johnson & Johnson from 1973 to 1989, including the position of VP Marketing & Sales for Vistakon, a Johnson & Johnson company. He also held the position of marketing director for the Johnson & Johnson Baby Products Company. Prior to joining Johnson & Johnson, Mr. Johnson was an account manager at Compton Advertising, servicing Procter & Gamble. Mr. Johnson was a board member of Scolr Pharma, Inc. from 2010 to 2013, including as chairman from 2011 to 2013. Mr. Johnson also previously served on the boards of the Generic Pharmaceutical Association and the Consumer Healthcare Products Association. Mr. Johnson holds a Master of Business Administration — Marketing from Fairleigh Dickinson University and a Bachelor of Science in Economics from Wagner College.
The Board of Directors of BMAC has determined that Mr. Hopkins and Mr. Johnson each meet the applicable standards of independence under the rules of The Nasdaq Stock Market LLC.
In connection with the appointment to the Board, Mr. Hopkins and Mr. Johnson are expected to separately enter into BMAC’s standard form of indemnification agreement for directors and officers and merger agreements to be bound by the same provisions of the individual Insider Letter Agreement, dated 18 October 2021, by and between BMAC and each of BMAC’s officers, directors and original shareholders.
About Blockchain Moon Acquisition Corp.
BMAC is a blank check company formed for the purpose of carrying out a business combination with one or more businesses. While there is no limitation or restriction on the industry or geographic region in which the target operates, BMAC intends to pursue potential targets that are high-growth companies in blockchain technologies in North America, Europe and Asia. The income from the offer will be used to finance such a business combination. The BMAC team consists of investors and leaders in the blockchain industry, including Enzo Villani, Chairman and CEO, Wes Levitt, CFO, and Board members John Jacobs, Michael Terpin, James Haft, David Shafrir, John P. Hopkins and Carl J Johnson. Visit www.BMAQ.io for more information.
Warning regarding forward-looking statements
This press release contains forward-looking statements that involve risk and uncertainty. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, including the successful completion of BMAC’s IPO and the pursuit of an initial business combination, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. BMAC expressly disclaims any obligation or duty to publish any updates or revisions to any forward-looking statements contained herein to reflect any change in BMAC’s expectations with respect thereto or any change in events, conditions or circumstances on which a statement is based .
